A Study to Assess Safety, Tolerability and Pharmacokinetics of Transdermal SFG-02 in Healthy Participants
Clinical trial NCT07167914 · COMPLETED
Trial details
- NCT number
- NCT07167914
- Sponsor
- Juro Sciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-09
- Primary completion
- 2026-04-27
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.